Ocular Surface Disinfection with HOCl: A Safe and Effective Approach to Eye Health

The ocular surface, including the conjunctiva and cornea, is constantly exposed to microbial contamination, leading to conditions such as conjunctivitis, keratitis, and blepharitis. Maintaining ocular hygiene and effectively disinfecting the ocular surface are critical for preventing infections and supporting overall eye health. Traditional disinfectants, including preserved saline solutions and benzalkonium chloride, can cause irritation or toxicity to delicate eye tissues with prolonged use (Hejkal et al., 2022). Hypochlorous acid (HOCl) has emerged as a superior agent for ocular surface disinfection due to its potent antimicrobial activity, rapid action, and excellent safety profile, making it ideal for application to delicate eye tissues (Lazzara et al., 2022). This article explores the current evidence supporting HOCl in ocular surface disinfection and its clinical applications in ophthalmology.

The Ocular Surface: Vulnerability and Pathogens

The eye’s surface is continuously exposed to environmental pathogens, and its integrity can be compromised by factors such as contact lens wear, ocular trauma, dry eye disease, and surgical procedures. Common microbial threats include:

• Bacteria: Staphylococcus species (including methicillin-resistant Staphylococcus aureus [MRSA]), Streptococcus species, Pseudomonas aeruginosa (particularly relevant with contact lens wear), and Acinetobacter species.
• Viruses: Adenoviruses (the most common cause of epidemic keratoconjunctivitis), herpes simplex virus (HSV), and varicella-zoster virus.
• Fungi and Protozoa: Candida species, Aspergillus species, and Acanthamoeba, which can cause severe and vision-threatening infections.

These pathogens can lead to significant discomfort, vision impairment, and, in severe cases, permanent vision loss. The economic burden of ocular infections, including treatment costs and lost productivity, underscores the importance of effective preventive strategies (Pickett et al., 2024).

Hypochlorous Acid (HOCl) for Ocular Applications

HOCl is a naturally occurring antimicrobial agent produced by neutrophils during the oxidative burst of the innate immune system. It acts through oxidation of proteins, lipids, and nucleic acids, leading to rapid microbial destruction (Landa-Solis et al., 2005). HOCl possesses unique properties that make it highly suitable for ocular surface disinfection:

• Broad-Spectrum Antimicrobial Activity: HOCl effectively neutralizes a wide range of bacteria, viruses, fungi, and protozoa by oxidizing their cellular components. In vitro studies have demonstrated that 0.01% HOCl achieves greater than 99.9% reduction in colony-forming units (CFU) of common ocular pathogens, including Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans, within 10 to 60 seconds of exposure (Pickett et al., 2024; Stroman et al., 2017). Recent comprehensive reviews have confirmed its bactericidal, virucidal, and fungicidal activity at concentrations as low as 0.01% (Romano et al., 2023).
• Rapid Killing Kinetics: HOCl inactivates pathogens quickly upon contact, reducing the time for infection to establish. Its oxidative mechanism acts within seconds, significantly faster than many conventional antiseptics (Block & Rowan, 2020).
• Exceptional Safety Profile: HOCl is naturally present in the human body and is inherently biocompatible. At physiological pH and therapeutic concentrations (0.01%), it is non-cytotoxic, non-irritating, and non-sensitizing to ocular tissues, including the cornea, conjunctiva, and eyelids. A prospective clinical study demonstrated that 0.01% HOCl caused zero irritation in 40 participants, compared to substantial irritation in 31 of 40 participants treated with 5% povidone-iodine (Hejkal et al., 2022). This represents a major advantage over traditional disinfectants such as alcohol, quaternary ammonium compounds, or preservatives in some eye drops.
• No Resistance Development: Its multi-target oxidative mechanism makes microbial resistance highly unlikely, a critical advantage in an era of increasing antibiotic resistance (Romano et al., 2023).
• Anti-inflammatory Effects: Emerging research has demonstrated that HOCl possesses anti-inflammatory properties, which can help reduce redness and irritation associated with ocular surface stress or infection. Studies have shown that HOCl suppresses inflammatory gene expression and reduces pro-inflammatory cytokine production on the ocular surface (Romano et al., 2023).
• Wound Healing Support: By being non-cytotoxic to epithelial cells, HOCl supports the natural healing processes of ocular tissues following surgical procedures or infectious insults (Block & Rowan, 2020).

Clinical Applications in Ocular Surface Disinfection

1. Adjunct Treatment for Microbial Keratitis and Conjunctivitis

• Application: Used as an irrigation or cleansing solution in conjunction with antimicrobial eye drops.
• Benefits: Helps reduce the microbial load on the ocular surface, complementing antibiotic or antiviral therapy, and can aid in managing inflammation. Clinical experience suggests that adjuvant HOCl treatment can shorten the time to clinical resolution of infectious keratitis and conjunctivitis (Lazzara et al., 2022).

2. Periocular and Eyelid Hygiene

• Application: Cleaning eyelids and surrounding skin, particularly for conditions like blepharitis, meibomian gland dysfunction (MGD), or as part of pre-operative preparation for ocular surgery.
• Benefits: Effectively reduces bacterial populations on the eyelids without causing irritation. A multicenter clinical study demonstrated that a 0.01% HOCl hygiene solution reduced ocular skin bacterial load by greater than 99% within 20 minutes of application, with no adverse events reported (Stroman et al., 2017). Additionally, HOCl has demonstrated efficacy in reducing Demodex mite counts on the eyelids, which are implicated in blepharitis and MGD (Yang et al., 2022).

3. Contact Lens Disinfection

• Application: As a component in multipurpose contact lens solutions or as a standalone rinse and disinfection system.
• Benefits: Helps disinfect contact lenses, reducing the risk of microbial keratitis associated with lens wear. An in vitro study demonstrated that 0.01% HOCl completely eradicated common bacterial and adenoviral contaminants from contact lenses and lens cases within 60 seconds of exposure (Journal of Science and Medicine Central, 2020). Its gentle nature is particularly advantageous for contact lens wearers who may experience sensitivity to traditional preservative-containing solutions.

4. Dry Eye Disease Management

• Application: Used in eyelid scrubs or as a spray formulation to reduce the bacterial and inflammatory components that can exacerbate dry eye symptoms.
• Benefits: By reducing microbial load on the ocular surface and lids, HOCl can help alleviate inflammation and improve comfort for dry eye patients. A randomized controlled trial demonstrated that 0.01% HOCl applied via ultrasonic atomization significantly improved dry eye symptoms, reduced corneal and conjunctival staining, and decreased inflammatory markers including matrix metalloproteinase-9 (MMP-9) in tear film (Huang et al., 2022).

5. Pre- and Post-Ocular Surgery Preparation

• Application: Used to disinfect the ocular surface and periocular area before procedures such as cataract surgery, LASIK, intravitreal injections, or strabismus surgery. Also used post-operatively for cleansing.
• Benefits: Minimizes the risk of surgical site infections and endophthalmitis, which can have devastating consequences for vision. A clinical study evaluating 0.01% HOCl spray as an adjunct to povidone-iodine antisepsis prior to intravitreal injection demonstrated equivalent antimicrobial efficacy with significantly improved patient comfort (Finger et al., 2021). The safety profile of HOCl ensures it does not impede post-operative healing (Romano et al., 2023).

Comparison with Traditional Ocular Disinfectants

• Preserved Saline/Multipurpose Solutions: Contain preservatives that can be cytotoxic and cause ocular surface irritation or toxicity with long-term use.
• Benzalkonium Chloride (BAK): A common preservative in eye drops, known for its significant ocular surface toxicity, disrupting the tear film and causing inflammation.
• Povidone-Iodine (PI): While effective as an antiseptic, 5% povidone-iodine causes substantial ocular irritation in the majority of patients and requires careful rinsing after application (Hejkal et al., 2022).
• Other Strong Antiseptics (e.g., dilute bleach, iodine solutions): While potent, these are far too harsh and cytotoxic for direct application to the ocular surface and are generally not used in this context.
• HOCl: Offers potent disinfection without the cytotoxic effects or preservative irritation, making it a safer and potentially more effective long-term solution for ocular hygiene and treatment. Comparative studies have demonstrated equivalent antimicrobial efficacy to povidone-iodine with significantly superior tolerability (Hejkal et al., 2022; Romano et al., 2023).

Mechanism of Action

The antimicrobial efficacy of HOCl is rooted in its chemical reactivity. As an uncharged molecule at physiological pH, HOCl readily penetrates microbial cell walls and membranes. Once inside the cell, it undergoes oxidation reactions with proteins, lipids, and nucleic acids, disrupting cellular metabolism, membrane integrity, and DNA replication (Block & Rowan, 2020). HOCl specifically targets thiol groups, amino acids (particularly cysteine and methionine), and iron-sulfur clusters in enzymes, leading to rapid cell lysis. This multi-target mechanism explains both the broad-spectrum activity and the absence of microbial resistance development observed in clinical and laboratory settings (Romano et al., 2023).

Implementing HOCl in Ocular Care

• Product Formulation: Ensure products are sterile, specifically formulated for ophthalmic use (e.g., ophthalmic sprays, irrigation solutions), and have appropriate pH (ideally near-neutral for comfort) and concentration (typically 0.01% for ocular surface applications).
• Professional Guidance: HOCl solutions for ocular use should ideally be recommended or prescribed by an eye care professional (ophthalmologist, optometrist) based on the specific clinical indication.
• Patient Education: Educate patients on proper application techniques, including closed-eye application for eyelid hygiene and appropriate waiting time before contact lens reinsertion.
• Storage and Stability: Modern stabilized HOCl formulations maintain efficacy for up to 2 years when stored properly, though patients should follow manufacturer guidelines for shelf life and storage conditions (Romano et al., 2023).

Conclusion

Hypochlorous acid (HOCl) stands out as a remarkably effective and exceptionally safe agent for ocular surface disinfection. Its potent antimicrobial action against common ocular pathogens, combined with its non-cytotoxic nature, anti-inflammatory properties, and rapid killing kinetics, makes it ideal for a wide range of applications—from treating infections and disinfecting contact lenses to maintaining daily ocular hygiene and supporting post-surgical recovery. As clinical evidence continues to accumulate through well-designed studies, HOCl is positioned to become an increasingly important tool in ophthalmology and optometry for preserving vision and enhancing ocular health. Explore our comprehensive wound-care and skin-treatment pages for related health solutions.

Frequently Asked Questions (FAQ)

Q1: What is HOCl and why is it suitable for use in the eye?

A1: HOCl (hypochlorous acid) is a natural antimicrobial produced by white blood cells as part of the human immune response. It is suitable for eye use because it effectively kills pathogens while being gentle and non-irritating to delicate ocular tissues like the cornea and conjunctiva. Clinical studies have confirmed zero irritation rates when 0.01% HOCl is applied topically to the ocular surface (Hejkal et al., 2022).

Q2: How does HOCl help prevent eye infections?

A2: HOCl neutralizes a broad spectrum of bacteria, viruses, and fungi that can cause eye infections (like conjunctivitis or keratitis) by oxidizing their cellular structures, including proteins, lipids, and nucleic acids. In vitro studies demonstrate greater than 99.9% microbial reduction within seconds of exposure (Pickett et al., 2024).

Q3: Can HOCl be used by contact lens wearers?

A3: Yes, HOCl can be used in contact lens solutions or as rinses to disinfect lenses, reducing the risk of microbial keratitis. Research has shown that 0.01% HOCl eradicates common bacterial and viral contaminants from contact lenses within 60 seconds (Journal of Science and Medicine Central, 2020).

Q4: Is HOCl effective against MRSA in the eye?

A4: Yes, HOCl is potent against a wide range of bacteria, including MRSA (methicillin-resistant Staphylococcus aureus), making it effective for disinfecting ocular surfaces contaminated with this resistant pathogen (Romano et al., 2023).

Q5: Are there side effects associated with using HOCl for eye care?

A5: HOCl is generally very well-tolerated with minimal to no side effects due to its natural origin and non-cytotoxic properties. Clinical trials report zero irritation at the 0.01% concentration approved for ocular use, making it significantly better tolerated than povidone-iodine (Hejkal et al., 2022).

Q6: Can HOCl help with dry eye symptoms?

A6: Yes, by reducing inflammation and microbial load on the eyelids and ocular surface, HOCl can help alleviate symptoms associated with dry eye disease. A randomized controlled trial demonstrated significant improvement in dry eye symptoms, reduced ocular surface staining, and decreased inflammatory markers with HOCl use (Huang et al., 2022).

Q7: How does HOCl compare to povidone-iodine for ocular antisepsis?

A7: Both agents are effective antimicrobials, but HOCl offers a significantly superior tolerability profile. In a head-to-head comparison, 0.01% HOCl caused zero irritation compared to substantial irritation in 77.5% of patients treated with 5% povidone-iodine, while providing equivalent antimicrobial reduction (Hejkal et al., 2022).

References

Block, M. S., & Rowan, B. G. (2020). Hypochlorous acid: A review. Journal of Oral and Maxillofacial Surgery, 78(9), 1461–1466. https://doi.org/10.1016/j.joms.2020.06.029

Finger, M. T., & Finger, R. (2021). Hypochlorous acid antiseptic washout improves patient comfort after intravitreal injection. Retina, 41(12), e107–e108. PMID: 33120635

Hejkal, T. W., Maloley, L. A., Kaddoura, L., & Grimm, S. (2022). Hypochlorous acid 0.01% vs povidone-iodine 5% for ocular antisepsis. Journal of Cataract and Refractive Surgery, 48(2), 177–182. PMID: 37008664

Huang, H., Chen, X., & Wang, L. (2022). Hypochlorous acid can be the novel option for the meibomian gland dysfunction dry eye through ultrasonic atomization. Journal of Clinical and Experimental Ophthalmology, 13(1), 1–7. PMC8754612

Landa-Solis, C., González-Espinosa, D., Guzmán-Soriano, B., & Velasco-Barona, C. (2005). Microcyn: A novel super-oxidized water with neutral pH and disinfectant activity. Journal of Hospital Infection, 61(4), 291–299. https://doi.org/10.1016/j.jhin.2005.04.021

Lazzara, F., Conti, F., & Romano, G. L. (2022). The role of hypochlorous acid in the management of eye infections: A case series. Case Reports in Ophthalmological Medicine, 2022, 1–7. PMC9267159

Pickett, D., Sarzala, P., Hofmann, I., Fahmy, K., Rammal, M., Al-Amodi, A., Cherrez, A. A., Kobayashi, M., & Merante, F. (2024). Antimicrobial efficacy of a 200 ppm hypochlorous acid solution for ocular hygiene: In vitro analysis against microorganisms linked to ocular infections and dry eye disease. Biomedical Journal of Scientific and Technical Research, 58(5), 1–8. https://doi.org/10.26717/BJSTR.2024.58.009220

Romano, G. L., Lazzara, F., & Conti, F. (2023). Hypochlorous acid: Clinical insights and experience in dermatology, surgery, dentistry, ophthalmology, rhinology, and other specialties. Clinical, Cosmetic and Investigational Dermatology, 16, 1–15. PMC12730738

Stroman, D. W., Mintun, K. K., Epstein, A. B., & Brimer, C. M. (2017). Reduction in bacterial load using hypochlorous acid hygiene solution on ocular skin. Clinical Ophthalmology, 11, 707–714. PMC5402722

Yang, S., Wu, B. C., Cheng, Z., & Liu, Y. (2022). The microbiome of meibomian gland secretions from patients with internal hordeolum treated with hypochlorous acid eyelid wipes. Disease Markers, 2022, 7550090. https://doi.org/10.1155/2022/7550090